Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Capital Pro-Égaux Inc. is a Canadian medical technology company that specialized in the design and manufacture of titanium products for the dental prosthesis restoration industry. Operating primarily through its subsidiary, Technique d'usinage Sinlab Inc., the company developed proprietary digital dentistry solutions, including the Technobar and Technoguide systems. For many years, the company's primary business model involved the licensing and enforcement of its extensive digital dentistry patent portfolio against major industry players. Following the expiration of its core patents and the resolution of significant litigation, the company has ceased active operations and is currently exploring strategic alternatives, including liquidation or a reverse takeover. It is currently listed on the NEX board of the TSX Venture Exchange under the symbol CPE.H but is subject to a cease trade order.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Capital Pro-Égaux.